The present invention relates to optimized formulations of antiinflammatory steroids
for nebulisation and a process for the preparation thereof. More particularly,
the invention relates to formulations for monodose or multidose vials in the form
of preservative-free stable solutions of a more acceptable osmolarity, which can
effectively be nebulised with the nebulisers currently available on the market
and are well-tolerated by patients.